2023/12 - Final RMB(¥) | %Chg (Final to Final) | 2022/12 RMB(¥) | 2021/12 RMB(¥) | 2020/12 RMB(¥) | 2019/12 RMB(¥) | ||
Interest Income | 236,165,000 | -5.707% | 250,458,000 | 269,629,000 | 304,952,000 | 320,349,000 | |
Interest Expense | (49,016,000) | -5.961% | (52,123,000) | (51,751,000) | (48,978,000) | (49,553,000) | |
Net Interest Income | 187,149,000 | -5.640% | 198,335,000 | 217,878,000 | 255,974,000 | 270,796,000 | |
Other Operating Income | (12,677,000) | -- | 9,930,000 | 34,066,000 | 7,681,000 | 14,172,000 | |
Total Operating Income | 174,472,000 | -16.226% | 208,265,000 | 251,944,000 | 263,655,000 | 284,968,000 | |
Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 | |
Net Operating Income | 174,472,000 | -16.226% | 208,265,000 | 251,944,000 | 263,655,000 | 284,968,000 | |
Operating Expenses | (52,881,000) | -1.002% | (53,416,000) | (57,658,000) | (52,750,000) | (59,761,000) | |
Impairment Losses on Loans & Advances | 7,836,000 | -- | (17,835,000) | (18,877,000) | (43,992,000) | (34,252,000) | |
Other Impairment Losses | 1,664,000 | -- | (4,419,000) | (2,246,000) | (4,841,000) | (2,473,000) | |
Operating Profit | 131,091,000 | -1.134% | 132,595,000 | 173,163,000 | 162,072,000 | 188,482,000 | |
Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 | |
Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 | |
Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 | |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 | |
Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
Profit / (Loss) before Taxation | 131,091,000 | -1.134% | 132,595,000 | 173,163,000 | 162,072,000 | 188,482,000 | |
Taxation | (34,455,000) | -4.022% | (35,899,000) | (45,465,000) | (44,249,000) | (47,694,000) | |
Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
Non-controlling Interests | (3,986,000) | 18.772% | (3,356,000) | (11,209,000) | (7,579,000) | (9,201,000) | |
Others | -- | -- | -- | -- | -- | -- | |
Profit / (Loss) Attributable to Shareholders | 92,650,000 | -0.739% | 93,340,000 | 116,489,000 | 110,244,000 | 131,587,000 | |
Depreciation & Amortisation | 6,276,000 | -22.814% | 8,131,000 | 8,249,000 | 7,884,000 | 8,608,000 | |
Directors' Emoluments | 2,943,000 | 1.099% | 2,911,000 | 2,785,000 | 2,594,000 | 2,166,000 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
EPS (cts) | 8.000 | -- | 8.000 | 10.000 | 9.000 | 11.000 |
DPS (cts) | 2.000 | -- | 4.000 | 5.000 | 0.000 | 0.000 |
Dividend Payout Ratio (%) | 25.000% | -- | 50.000% | 50.000% | -- | -- |
Cash flow per share ($) | 0.241 | -- | -0.005 | 0.060 | 0.126 | 0.079 |
NBV per share ($) | 1.648 | -- | 1.609 | 1.580 | 1.481 | 1.387 |
Remarks: | Real time quote last updated: 19/04/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (¥) | RMB 92,650,000 |
%Change | -0.739% |
EPS / (LPS) | RMB 0.080 |
NBV Per Share (¥) | RMB 1.648 |